1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. Btk
  4. Btk Ligand

Btk Ligand

Btk Ligands (7):

Cat. No. Product Name Effect Purity
  • HY-49421
    BTK ligand 12
    Ligand 98.23%
    BTK ligand 12 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). BTK ligand 12 can serve as an active control for the target protein ligand of NRX-0492 (HY-153357).
  • HY-182933
    BTK ligand-20
    Ligand
    BTK ligand-20 (compound 1) is a BTK ligand. BTK ligand-20 serves as a target protein ligand for the synthesis of PROTAC BTK Degrader-15 (HY-182910). BTK ligand-20 is applicable to cancer research.
  • HY-171893
    CRBN ligand-185
    Ligand
    CRBN ligand-185 is a CRBN ligand. CRBN ligand-185 can be used as a target protein ligand for the synthesis of PROTACs targeting CRBN (Ligands for Target Protein for PROTAC), such as NX-5948 (HY-153321).
  • HY-179076
    BTK/IKZF1/3 ligand 1
    Ligand
    BTK/IKZF1/3 ligand 1 is a BTK/IKZF1/3 PROTAC ligand. BTK/IKZF1/3 ligand 1 can be conjugated with E3 ligase Ligand (HY-41547) and linker to synthesize PROTAC BTK/IKZF1/3 Degrader-1 (HY-179077). PROTAC BTK/IKZF1/3 Degrader-1 can be used for cancer research.
  • HY-175543
    BTK ligand 16
    Ligand
    BTK ligand 16 is a BTK ligand that can be used for synthesis of TQ-3959 (HY-175541).
  • HY-175788
    BTK ligand-17
    Ligand
    BTK ligand-17 (The Target Protein Ligand Moiety of Catadegbrutinib) is a BTK ligand. BTK can be used as Ligands for Target Protein for PROTAC to develop and design degradative agents for PROTAC BTKs, such as Catadegbrutinib (HY-160141). BTK ligand-17 can also be used in cancer research.
  • HY-181624
    BTK ligand-19
    Ligand
    BTK ligand-19 is a PROTAC ligand of BTK, which is used to synthesize the PROTAC-based BTK degrader PROTAC BTK degrader-14 (HY-181623). BTK ligand-19 regulates cell apoptosis, cell cycle progression and kinase signaling cascades. BTK ligand-19 is applied in cancer research.